LCMS
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike
Organizer
Evosep Biosystems
Evosep Biosystems
Evosep develops new solutions to make clinical proteomics 100 times more robust and 10 times faster. We are basing our design on years of experience with nano-UHPLC R&D and application support, critically rethinking the necessary system architectures for successful sample separation before mass spectrometric analysis.
Tags
OMICS
LC/MS
LC/MS/MS
LC/QQQ
LinkedIn Logo

Targeted Workflows

RECORD | Already taken place Th, 20.11.2025
Discover how the Evosep Eno–Waters Xevo TQ Absolute LC-MS platform delivers high-throughput, sensitive, and reproducible quantification of plasma protein biomarkers for clinical research.
Go to the webinar
Evosep Biosystems: Targeted Workflows
Evosep Biosystems: Targeted Workflows

Push the boundaries of targeted proteomic LC-MS workflows designed for unmatched sensitivity, reproducibility, and throughput. See how streamlined methods enable confident protein quantification and accelerate validation across large cohorts with ease.

Advancing Protein Biomarker Quantification: Performance Evaluation of the Evosep Eno – Waters Xevo TQ Absolute LC-MS Platform
  • Margrét Þorsteinsdóttir and Finnur Freyr Eiriksson, University of Iceland
  • Iulia Macavei, Scientist, Proteomics research at evosep

This webinar presentation highlights a robust, high-throughput LC–MS platform integrating the Evosep Eno with the Waters Xevo TQ Absolute for precise and reproducible quantification of plasma protein biomarkers. The workflow delivers exceptional sensitivity, reproducibility, and throughput, enabling reliable quantitative results for early myocardial infarction risk prediction. Optimization of bottom-up proteomics sample preparation using a Design of Experiments strategy and implementation of an automated process further improved robustness and scalability. Together, these advancements show that the Evosep Eno – Waters Xevo TQ Absolute platform provides a powerful, efficient solution to accelerate the translation of biomarker discovery into clinical research.

Evosep Biosystems
LinkedIn Logo
 

Related content

Robustness in Regulated Bioanalysis: A 30,000 Injection Study of Naltrexone in Human Plasma using the Xevo™ TQ Absolute XR Mass Spectrometer

Applications
| 2025 | Waters
Instrumentation
LC/MS, LC/MS/MS, LC/QQQ
Manufacturer
Waters
Industries
Pharma & Biopharma, Clinical Research

Seized Drug Analysis Using ASAP-MS and Multivariate Analysis Models

Posters
| 2025 | Waters (TIAFT)
Instrumentation
LC/MS, LC/SQ, DART
Manufacturer
Waters
Industries
Forensics

Sensitive and selective quantitation of bile acids using targeted MS2/MS3 on the Stellar mass spectrometer

Posters
| 2025 | Thermo Fisher Scientific (MSACL)
Instrumentation
LC/MS, LC/MS/MS, LC/Orbitrap, LC/HRMS
Manufacturer
Thermo Fisher Scientific
Industries
Clinical Research

Selective and sensitive measurement of 17 steroids in human serum using a Stellar mass spectrometer

Technical notes
| 2025 | Thermo Fisher Scientific
Instrumentation
LC/MS, LC/MS/MS, LC/Orbitrap, LC/HRMS
Manufacturer
Thermo Fisher Scientific
Industries
Clinical Research

Automated Multiple Reaction Monitoring (MRM) Method Development for Peptide Drugs Using waters_connect for Quantitation Software

Applications
| 2025 | Waters
Instrumentation
Software, LC/MS, LC/MS/MS, LC/QQQ
Manufacturer
Waters
Industries
Pharma & Biopharma
Other projects
GCMS
ICPMS
Follow us
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike